1. Home
  2. ZNTL vs IACQ Comparison

ZNTL vs IACQ Comparison

Compare ZNTL & IACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$1.37

Market Cap

165.1M

Sector

Health Care

ML Signal

HOLD

IACQ

Irenic Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.94

Market Cap

322.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNTL
IACQ
Founded
2014
2026
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.1M
322.4M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
ZNTL
IACQ
Price
$1.37
$9.94
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $7.44
N/A
AVG Volume (30 Days)
★ 1.3M
27.5K
Earning Date
11-09-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 18.03
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.30
$9.89
52 Week High
$6.95
$10.10

Technical Indicators

Market Signals
Indicator
ZNTL
IACQ
Relative Strength Index (RSI) 23.27 49.81
Support Level N/A $9.89
Resistance Level $1.98 $10.00
Average True Range (ATR) 0.18 0.01
MACD -0.01 0.00
Stochastic Oscillator 8.82 60.00

Price Performance

Historical Comparison
ZNTL
IACQ

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About IACQ Irenic Acquisition Corp. Class A Ordinary Shares

Irenic Acquisition Corp is a blank check company with no operations.

Share on Social Networks: